CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Women with Breast Cancer: A Randomized, Sham-Controlled Trial [PDF]
Cancers (Basel)Sireen Jaber +3 more
openalex +2 more sources
Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life [PDF]
Гинекология, 2022 Vulvovaginal atrophy (VVA) is detected in more than 50% of postmenopausal women, and at 4049 years of age, 15-19% of women have relevant signs. Atrophic changes in the female urogenital system are associated with hypoestrogenism, which results in the ...
Mekan R. Orazov +5 more
doaj +1 more source
Multifaceted Impact of CO2 Laser Therapy on Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy and Sexual Function. [PDF]
Healthcare (Basel)Genitourinary syndrome of menopause (GSM) encompasses a range of distressing symptoms in the vulvovaginal and/or bladder–urethral regions related to menopause changes, negatively influencing woman’s quality of life and sexual activity.
Jankovic S +5 more
europepmc +2 more sources
Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors A Viable Possibility? [PDF]
, 2023 Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia.
MENDOZA, NICOLAS, Quereda, Francisco
core +4 more sources
JAMA Network Open, 2023 Key Points Question Is vaginal laser treatment safe and effective for genitourinary syndrome of menopause in survivors of breast cancer receiving aromatase inhibitors?
E. Mensión +16 more
semanticscholar +1 more source
Neurourology and Urodynamics, Volume 42, Issue 1, Page 133-145, January 2023., 2023 Abstract Background A variety of factors influence bladder health, including environmental factors, life experiences, biologic foundations, and coexistent medical conditions. A biologically diverse microbial community exists in the urine that is likely influenced by the microbial inhabitants of the vagina. The relationship between the genitourinary (GU)
Margaret G. Mueller +9 more
wiley +1 more source
Laser therapy for genitourinary syndrome of menopause: systematic review and meta-analysis of randomized controlled trial. [PDF]
Rev Bras Ginecol ObstetObjective: This meta-analysis of randomized controlled trials (RCTs) aimed to update evidence on the effectiveness and safety of laser therapy for treating genitourinary syndrome of menopause (GSM). Data sources: Manuscripts published until May 2023 were
Pessoa LLMN +8 more
europepmc +2 more sources
BMC Women's Health, 2021 Background Genitourinary syndrome of menopause (GSM) involves vaginal dryness (VD), pain during sexual activity (SAPain), vaginal itching (VI), burning, pain, and symptoms in the urinary organs.
Cintia Pinheiro +7 more
doaj +1 more source
Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review
Гинекология, 2023 The real-world treatment of genitourinary syndrome of menopause has several limitations: contraindications to topical estrogen therapy, which is currently recognized as the "gold standard" treatment for vulvovaginal atrophy (VVA), fear of the systemic ...
Mekan R. Orazov +5 more
doaj +1 more source
Clinical characteristics and treatment modalities of vulvovaginal atrophy in genitourinary syndrome of menopause [PDF]
, 2022 Background: Genitourinary syndrome of menopause (GSM) causes symptoms such as vaginal dryness, dysuria, repetitive urinary tract infection and urinary urgency may affect daily activities, sexual relationships, and overall quality of life.
Cho, Hae Jung +3 more
core +2 more sources